Skip to content

Group Reality Therapy on adherence to the therapeutic regimen and improvement of health indicators in Diabetes patient

Comparison of the effectiveness of group reality therapy with a routine education program on adherence to the therapeutic regimen and improvement of health indicators in patients with Diabetes Type 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181210041915N2
Enrollment
60
Registered
2020-10-06
Start date
2019-12-10
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: The treatment protocol of the intervention group consisted of 10 sessions of 45 minutes (one session per week) for 2 months in the form of lectures and face-to-face

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Having minimum literacy skills Not working, spouse or first-degree relatives in health centers Willingness to participate in the study At least two months have passed since diagnosis of diabetes Not having a history of uncontrolled underlying diseases such as epilepsy The patient has never received any training in the field of reality therapy

Exclusion criteria

Exclusion criteria: Not participating in more than one training session Psychiatric treatments or the use of psychotropic drugs and substance abuse during study

Design outcomes

Primary

MeasureTime frame
Score of adherence to therapeutic regime based on questionnaire of adherence to therapeutic regime in patients with diabetes. Timepoint: The measurement of adherence to therapeutic regime was measured before the study, 1 and 2 months after the start of the group reality therapy. Method of measurement: Questionnaire of adherence to therapeutic regime in patients with diabetes.;Primary variable was cholesterol levels. Timepoint: The measurement of blood cholesterol level before the study, 1 and 2 months after the start of group reality therapy. Method of measurement: Cholesterol level detection kit in the laboratory.;Primary variable was Blood Gloucester Hemoglobin( HBA1C) levels. Timepoint: level of Blood Gloucester Hemoglobin (A1C Hb) before the study, 1 and 2 months after the start of the group reality therapy was measured. Method of measurement: The HbA1C hemoglobin measurement kit in the laboratory was used.;Fasting Blood Sugar level. Timepoint: level of Fasting Blood Sugar before of the study, 1 and 2 months after the start of the group reality therapy was measured. Method of measurement: The Fasting Blood Sugar measurement kit in the laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkourosh zarea

Ahvaz University of Medical Sciences

zarea_k@ajums.ac.ir+98 61 3373 8621

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026